Mounjaro (Tirzepatide) Prescribing Update

From 23 June 2025, following approval by NICE, tirzepatide (Mounjaro®) will be available in the NHS for eligible patients who meet the strict, nationally-set, criteria. 

PCMS Logo

Leading Change Through Innovation

Asthma

Asthma is a common lung condition that causes occasional breathing difficulties.

It affects people of all ages and often starts in childhood, although it can also develop for the first time in adults.

There’s currently no cure, but there are simple treatments that can help keep the symptoms under control so it doesn’t have a big impact on your life.